124 related articles for article (PubMed ID: 24835925)
21. Self-Delivery Nanoparticles of Amphiphilic Methotrexate-Gemcitabine Prodrug for Synergistic Combination Chemotherapy via Effect of Deoxyribonucleotide Pools.
Wang Y; Huang P; Hu M; Huang W; Zhu X; Yan D
Bioconjug Chem; 2016 Nov; 27(11):2722-2733. PubMed ID: 27723981
[TBL] [Abstract][Full Text] [Related]
22. Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides.
Vale N; Ferreira A; Fernandes I; Alves C; Araújo MJ; Mateus N; Gomes P
Bioorg Med Chem Lett; 2017 Jul; 27(13):2898-2901. PubMed ID: 28495087
[TBL] [Abstract][Full Text] [Related]
23. Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.
Li L; Tong R; Li M; Kohane DS
Acta Biomater; 2016 Mar; 33():34-9. PubMed ID: 26826531
[TBL] [Abstract][Full Text] [Related]
24. Enhanced cellular uptake and intracellular drug controlled release of VESylated gemcitabine prodrug nanocapsules.
Fang Y; Du F; Xu Y; Meng H; Huang J; Zhang X; Lu W; Liu S; Yu J
Colloids Surf B Biointerfaces; 2015 Apr; 128():357-362. PubMed ID: 25746328
[TBL] [Abstract][Full Text] [Related]
25. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
[TBL] [Abstract][Full Text] [Related]
26. Long-circulating and liver-targeted nanoassemblies of cyclic phosphoryl N-dodecanoyl gemcitabine for the treatment of hepatocellular carcinoma.
Du L; Zhang B; Lei Y; Wang S; Jin Y
Biomed Pharmacother; 2016 Apr; 79():208-14. PubMed ID: 27044830
[TBL] [Abstract][Full Text] [Related]
27. Nanomized tumor-microenvironment-active NIR fluorescent prodrug for ensuring synchronous occurrences of drug release and fluorescence tracing.
Li Q; Cao J; Wang Q; Zhang J; Zhu S; Guo Z; Zhu WH
J Mater Chem B; 2019 Mar; 7(9):1503-1509. PubMed ID: 32255021
[TBL] [Abstract][Full Text] [Related]
28. Squalenoylation: a generic platform for nanoparticular drug delivery.
Desmaële D; Gref R; Couvreur P
J Control Release; 2012 Jul; 161(2):609-18. PubMed ID: 21840355
[TBL] [Abstract][Full Text] [Related]
29. Thiophene-expanded guanosine analogues of Gemcitabine.
Chen Z; Ku TC; Seley-Radtke KL
Bioorg Med Chem Lett; 2015 Oct; 25(19):4274-6. PubMed ID: 26316465
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.
Yin N; Yu H; Zhang X; Lv X
Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890
[TBL] [Abstract][Full Text] [Related]
31. Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.
Bergman AM; Adema AD; Balzarini J; Bruheim S; Fichtner I; Noordhuis P; Fodstad O; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Invest New Drugs; 2011 Jun; 29(3):456-66. PubMed ID: 20066470
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine.
Bender DM; Bao J; Dantzig AH; Diseroad WD; Law KL; Magnus NA; Peterson JA; Perkins EJ; Pu YJ; Reutzel-Edens SM; Remick DM; Starling JJ; Stephenson GA; Vaid RK; Zhang D; McCarthy JR
J Med Chem; 2009 Nov; 52(22):6958-61. PubMed ID: 19860433
[TBL] [Abstract][Full Text] [Related]
33. Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics.
Hou M; Xue P; Gao YE; Ma X; Bai S; Kang Y; Xu Z
Biomater Sci; 2017 Aug; 5(9):1889-1897. PubMed ID: 28681888
[TBL] [Abstract][Full Text] [Related]
34. Chlorambucil gemcitabine conjugate nanomedicine for cancer therapy.
Fan M; Liang X; Li Z; Wang H; Yang D; Shi B
Eur J Pharm Sci; 2015 Nov; 79():20-6. PubMed ID: 26342774
[TBL] [Abstract][Full Text] [Related]
35. Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: Reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells.
Xu Y; Huang Y; Zhang X; Lu W; Yu J; Liu S
Int J Pharm; 2018 Oct; 550(1-2):45-56. PubMed ID: 30138703
[TBL] [Abstract][Full Text] [Related]
36. Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery.
Sobot D; Mura S; Yesylevskyy SO; Dalbin L; Cayre F; Bort G; Mougin J; Desmaële D; Lepetre-Mouelhi S; Pieters G; Andreiuk B; Klymchenko AS; Paul JL; Ramseyer C; Couvreur P
Nat Commun; 2017 May; 8():15678. PubMed ID: 28555624
[TBL] [Abstract][Full Text] [Related]
37. Preparation of intravenous injection nanoformulation of VESylated gemcitabine by co-assembly with TPGS and its anti-tumor activity in pancreatic tumor-bearing mice.
Xu Y; Meng H; Du F; Lu W; Liu S; Huang J; Yu J
Int J Pharm; 2015 Nov; 495(2):792-7. PubMed ID: 26410754
[TBL] [Abstract][Full Text] [Related]
38. Design, characterization, and in vitro antiproliferative efficacy of gemcitabine conjugates based on carboxymethyl glucan.
Ma L; Chen Y; Wang X; Xiong M; Sun Y; Zhang X; Zhao Y
Bioorg Med Chem Lett; 2018 Sep; 28(17):2920-2924. PubMed ID: 30017318
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticles with in vivo anticancer activity from polymer prodrug amphiphiles prepared by living radical polymerization.
Harrisson S; Nicolas J; Maksimenko A; Bui DT; Mougin J; Couvreur P
Angew Chem Int Ed Engl; 2013 Feb; 52(6):1678-82. PubMed ID: 23255475
[No Abstract] [Full Text] [Related]
40. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy.
Arya G; Vandana M; Acharya S; Sahoo SK
Nanomedicine; 2011 Dec; 7(6):859-70. PubMed ID: 21550422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
